Dr Emmanuel S Antonarakis from the University of Minnesota in Minneapolis and Professor Karim Fizazi from the Institut Gustave Roussy in Villejuif, France, provide their perspectives on relevant new clinical data in prostate cancer and discuss their application to the care of patients.

CME information and select publications here.

Clinical investigators discuss available data guiding the management of non-Hodgkin lymphoma. 

CME information and select publications here.

Clinical investigators discuss available data guiding the management of gynecologic cancers. 

CME information and select publications here.

Dr John P Leonard from Weill Cornell Medicine in New York, New York, reviews data presented at the 2024 ASH Annual Meeting and their implications for the treatment of non-Hodgkin lymphomas.

CME information and select publications here.

Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.

CME information and select publications here.

Dr Jennifer R Brown from Dana-Farber Cancer Institute in Boston and Prof Paolo Ghia from IRCCS Ospedale San Raffaele in Milano, Italy, summarize clinically relevant research findings and datasets over the past year regarding the treatment of chronic lymphocytic leukemia.

CME information and select publications here.

Clinical investigators discuss available data guiding the management of EGFR mutation-positive non-small cell lung cancer. 

CME information and select publications here.

Clinical investigators discuss available data guiding the management of prostate cancers. 

CME information and select publications here.